Celtaxsys

OverviewSuggest Edit

Celtaxsys is a pharmaceutical company developing treatments for patients with rare inflammatory diseases including cystic fibrosis. It provides an investigational medicine, acebilustat, as a once-daily, oral therapy for the treatment of lung inflammation associated with cystic fibrosis that has the potential of doing so without immune suppression.

TypePrivate
Founded2004
HQAtlanta, GA, US
Websiteceltaxsys.com

Locations

Celtaxsys is headquartered in
Atlanta, United States

Location Map

Latest Updates

Employees (est.) (Jul 2020)6
Cybersecurity ratingAMore

Celtaxsys Office Locations

Celtaxsys has offices in Atlanta and Brisbane City
Atlanta, GA, US (HQ)
201 17th St NW #530
Brisbane City, AU
level 15/300 Queen St
Show all (2)

Celtaxsys Financials and Metrics

Summary Metrics

Founding Date

2004

Celtaxsys total Funding

$53.1 m

Celtaxsys latest funding size

$40 m

Time since last funding

6 years ago

Celtaxsys investors

Celtaxsys's latest funding round in June 2015 was reported to be $40 m. In total, Celtaxsys has raised $53.1 m
Show all financial metrics

Celtaxsys Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

Celtaxsys Online and Social Media Presence

Embed Graph

Celtaxsys Frequently Asked Questions

  • When was Celtaxsys founded?

    Celtaxsys was founded in 2004.

  • How many employees does Celtaxsys have?

    Celtaxsys has 6 employees.

  • Who are Celtaxsys competitors?

    Competitors of Celtaxsys include MyoKardia, Ironwood Pharmaceuticals and Athersys.

  • Where is Celtaxsys headquarters?

    Celtaxsys headquarters is located at 201 17th St NW #530, Atlanta.

  • Where are Celtaxsys offices?

    Celtaxsys has offices in Atlanta and Brisbane City.

  • How many offices does Celtaxsys have?

    Celtaxsys has 2 offices.